PUBLISHER: The Business Research Company | PRODUCT CODE: 1670279
PUBLISHER: The Business Research Company | PRODUCT CODE: 1670279
Lyophilization services for biopharmaceuticals involve the freeze-drying of biopharmaceutical products to enhance stability, extend shelf life, and facilitate storage and transportation. This method effectively preserves and stabilizes biopharmaceuticals by removing water from the product in a frozen state.
The key categories within lyophilization services for biopharmaceuticals include product and cycle development, clinical manufacturing, commercial manufacturing, and freeze-drying analytical services. Product and cycle development encompass the process of designing, developing, and optimizing a product along with its manufacturing cycle. This includes the utilization of various packaging systems, such as vials, syringes, cartridges, ampoules, and others. These services cater to diverse applications, including pharmaceutical and biotechnology companies, research institutes, and other relevant industries.
The lyophilization services for biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides lyophilization services for biopharmaceuticals market statistics, including lyophilization services for biopharmaceuticals industry global market size, regional shares, competitors with a lyophilization services for biopharmaceuticals market share, detailed lyophilization services for biopharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the lyophilization services for biopharmaceuticals industry. This lyophilization services for biopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The lyophilization services for biopharmaceuticals market size has grown rapidly in recent years. It will grow from $1.82 billion in 2024 to $2.01 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to biopharmaceutical expansion, drug patent expirations, rise in personalized medicine, increase in clinical trials, and globalization of the biopharmaceutical market
The lyophilization services for biopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the emergence of MRNA and nucleic acid therapeutics, outsourcing trends in pharma industry, focus on continuous manufacturing, advancements in combination therapies, growth of biosimilars production. Major trends in the forecast period include quality-by-design (QBD) implementation, automation and robotics integration, focus on sustainability, customization for complex molecules, and shift towards continuous lyophilization.
The increasing demand for biologics is anticipated to drive the growth of lyophilization services in the biopharmaceuticals market in the future. Biologics are therapeutic products derived from living organisms or containing components from them, and lyophilization services are frequently employed for biologics in the pharmaceutical and biopharmaceutical sectors. This process helps maintain the stability of biologics by preventing denaturation or degradation, enhancing stability, and improving product integrity. For instance, reports from the Canadian Institute for Health Information, a government health organization in Canada, indicated that biologics accounted for 2.3% of claims and $4.4 billion (29.4%) of total spending on public medication programs in 2021. Additionally, the US Food and Drug Administration, a federal agency under the Department of Health and Human Services, reported that by the end of 2022, 40 biosimilars had received approval, with 27 available in the United States, competing against 10 brand-name biologics. Therefore, the growing demand for biologics is driving the need for lyophilization services in the biopharmaceuticals market.
The growth of lyophilization services for the biopharmaceuticals market is expected to be fueled by rising disposable incomes. Disposable income refers to the amount of money individuals or households have available to spend or save after taxes and other mandatory deductions. As disposable incomes increase, individuals and healthcare systems are generally better positioned to invest in advanced medical treatments, such as biopharmaceuticals. This heightened demand can result in greater investment in the development and manufacturing of these products, including specialized services like lyophilization. For example, according to the Statistics Bureau of Japan, a government agency that provides official macroeconomic and statistical data, Japan's disposable personal income rose to $3,058 in August from $2,402 in May 2022. Additionally, the U.S. Bureau of Economic Analysis, a government agency that provides official macroeconomic and industry statistics, reported that disposable personal income in the United States increased to $18,604.35 billion in June from $18,481.16 billion in May 2022. Thus, the rise in disposable incomes is driving the growth of lyophilization services in the biopharmaceuticals market.
Leading companies in the lyophilization services for biopharmaceuticals market are developing technologies such as modular design to improve flexibility and scalability in production processes, enhance equipment utilization efficiency, and facilitate faster adaptation to evolving manufacturing demands. Modular design involves breaking down a system into smaller, self-contained units or modules, which allows for flexibility, easy customization, and efficient reconfiguration or replacement of components without disrupting the entire system. For example, in June 2024, Syntegon Technology, a Germany-based machine industry company, introduced the Modular Bioprocessing Platform (MBP). This platform is modular in nature, allowing customization for various applications, including microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. This design enables biopharmaceutical manufacturers to quickly adjust to changing production requirements while maintaining quality.
Major companies in the lyophilization services for biopharmaceuticals market are actively engaging in strategic collaborations to drive innovation in drug product development, particularly for novel modalities in the biologics sector. An illustrative collaboration occurred in July 2023 between Coriolis Pharma, a Germany-based service provider and formulation R&D company, and RheaVita, a Belgium-based supplier of continuous freeze-drying technology for biopharmaceutical products. This collaboration aims to integrate RheaVita's single vial unit (SVU) technology into Coriolis Pharma's service portfolio. The SVU technology enables continuous and controlled freeze-drying, contributing to the stabilization of novel modalities as part of biologic drug product development.
In June 2024, Bora Pharmaceuticals Co. Ltd., a pharmaceutical company based in Taiwan, acquired Emergent BioSolutions Inc. for an undisclosed amount. This acquisition is intended to enhance Bora Pharmaceuticals' product portfolio, expand its market presence, and strengthen its research and development capabilities. Emergent BioSolutions Inc. is a US-based company that produces a variety of biopharmaceutical products.
Major companies operating in the lyophilization services for biopharmaceuticals market include Strides Pharma Science Limited, Baxter International Inc., Catalent Pharma Solutions Inc, Emergent BioSolutions Inc., Vetter Pharma International GmbH, Curia Global Inc., Corden Pharma GmbH, Lyophilization Services of New England Inc., Jubilant HollisterStier LLC, Dalton Pharma Services, IDT Biologika GmbH, Ardena Group, Axcellerate Pharma LLC, Symbiosis Pharmaceutical Services, Biofortuna Limited, Rentschler Fill Solutions GmbH, Lyophilization Technology Inc., Pyramid Laboratories Inc, AB BioTechnologies Inc., Biopharma Process Systems, Labyrinth Biopharma LLC, Gilyos GmbH, ProJect Pharmaceutics GmbH, BioZed Engineering Pvt. Ltd., Berkshire Sterile Manufacturing, Millrock Technology Inc.
North America was the largest region in the lyophilization services for biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyophilization services for biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the lyophilization services for biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lyophilization services for biopharmaceuticals market includes revenues earned by entities by providing scale-up and manufacturing, process optimization services, packaging solutions, stability studies, regulatory support, consulting, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lyophilization Services For Biopharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lyophilization services for biopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for lyophilization services for biopharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lyophilization services for biopharmaceuticals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.